China Regenerative Medicine International Limited

SEHK:8158 주식 보고서

시가총액: HK$97.4m

China Regenerative Medicine International 과거 수익 실적

과거 기준 확인 0/6

China Regenerative Medicine International은 연평균 68.1%의 비율로 수입이 증가해 온 반면, Biotechs 산업은 연평균 31.7%의 비율로 수입이 증가했습니다. 매출은 연평균 2.8%의 비율로 증가했습니다.

주요 정보

68.1%

수익 성장률

84.5%

EPS 성장률

Biotechs 산업 성장11.0%
매출 성장률2.8%
자기자본 수익률-412.3%
순이익-188.2%
최근 수익 업데이트30 Jun 2024

최근 과거 실적 업데이트

Recent updates

Little Excitement Around China Regenerative Medicine International Limited's (HKG:8158) Revenues As Shares Take 32% Pounding

Mar 05
Little Excitement Around China Regenerative Medicine International Limited's (HKG:8158) Revenues As Shares Take 32% Pounding

China Regenerative Medicine International Limited's (HKG:8158) Price Is Right But Growth Is Lacking After Shares Rocket 57%

Jan 04
China Regenerative Medicine International Limited's (HKG:8158) Price Is Right But Growth Is Lacking After Shares Rocket 57%

These 4 Measures Indicate That China Regenerative Medicine International (HKG:8158) Is Using Debt Extensively

Sep 21
These 4 Measures Indicate That China Regenerative Medicine International (HKG:8158) Is Using Debt Extensively

China Regenerative Medicine International Limited (HKG:8158) May Have Run Too Fast Too Soon With Recent 31% Price Plummet

Jun 11
China Regenerative Medicine International Limited (HKG:8158) May Have Run Too Fast Too Soon With Recent 31% Price Plummet

Is China Regenerative Medicine International (HKG:8158) A Risky Investment?

May 22
Is China Regenerative Medicine International (HKG:8158) A Risky Investment?

Is China Regenerative Medicine International (HKG:8158) A Risky Investment?

Apr 13
Is China Regenerative Medicine International (HKG:8158) A Risky Investment?

Does China Regenerative Medicine International (HKG:8158) Have A Healthy Balance Sheet?

Sep 22
Does China Regenerative Medicine International (HKG:8158) Have A Healthy Balance Sheet?

Introducing China Regenerative Medicine International (HKG:8158), The Stock That Zoomed 142% In The Last Year

Mar 16
Introducing China Regenerative Medicine International (HKG:8158), The Stock That Zoomed 142% In The Last Year

What Is The Ownership Structure Like For China Regenerative Medicine International Limited (HKG:8158)?

Feb 08
What Is The Ownership Structure Like For China Regenerative Medicine International Limited (HKG:8158)?

Trade Alert: The CEO & Executive Chairman Of China Regenerative Medicine International Limited (HKG:8158), Chuang Wang, Has Just Spent HK$55m Buying 428% More Shares

Dec 15
Trade Alert: The CEO & Executive Chairman Of China Regenerative Medicine International Limited (HKG:8158), Chuang Wang, Has Just Spent HK$55m Buying 428% More Shares

Don't Ignore The Fact That This Insider Just Sold Some Shares In China Regenerative Medicine International Limited (HKG:8158)

Nov 25
Don't Ignore The Fact That This Insider Just Sold Some Shares In China Regenerative Medicine International Limited (HKG:8158)

Does China Regenerative Medicine International (HKG:8158) Have A Healthy Balance Sheet?

Nov 24
Does China Regenerative Medicine International (HKG:8158) Have A Healthy Balance Sheet?

수익 및 비용 분석

China Regenerative Medicine International 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.


수익 및 매출 내역

SEHK:8158 수익, 비용 및 수입 (HKD Millions )
날짜수익수익G+A 비용R&D 비용
30 Jun 2455-104490
31 Mar 2445-101480
31 Dec 2369-108460
30 Sep 23-351400
30 Jun 232915340
31 Mar 232345300
31 Dec 22425260
30 Sep 2224631230
30 Jun 2225426220
31 Mar 222944920
31 Dec 212835260
30 Sep 21274-95140
30 Jun 21248-82-160
31 Mar 21222-105460
31 Dec 20182-120480
30 Sep 20110-201460
30 Jun 2057-237970
31 Mar 2012-239610
31 Dec 1919-2641000
30 Sep 1915-1,0053730
30 Jun 1919-1,0424240
31 Mar 1956-1,1775640
31 Dec 1873-1,1945980
30 Sep 18555-3464820
30 Jun 18607-3374890
31 Mar 18642-2374690
31 Dec 17756-2384920
31 Oct 17489-1714310
30 Jul 17425-1694160
30 Apr 17357-1853890
31 Jan 17284-1822820
31 Oct 1651-2613420
31 Jul 1629-2233450
30 Apr 1628-1913030
31 Jan 1618-2692370
31 Oct 156-2431870
31 Jul 154-2591520
30 Apr 153-2501340
31 Jan 152-2991580
31 Oct 142-2921250
31 Jul 141-2811220
30 Apr 141-2631130
31 Jan 140-103950

양질의 수익: 8158 은(는) 현재 수익성이 없습니다.

이익 마진 증가: 8158 은(는) 현재 수익성이 없습니다.


잉여현금흐름 대 수익 분석


과거 수익 성장 분석

수익추이: 8158 은(는) 수익성이 없지만 지난 5년 동안 연간 68.1% 의 비율로 손실을 줄였습니다.

성장 가속화: 현재 수익성이 없기 때문에 8158 의 지난 1년 동안의 수익 성장을 5년 평균과 비교할 수 없습니다.

수익 대 산업: 8158 은(는) 수익성이 없어 지난 해 수익 성장을 Biotechs 업계( 4% )와 비교하기 어렵습니다.


자기자본 수익률

높은 ROE: 8158 현재 수익성이 없기 때문에 마이너스 자본 수익률( -412.31% )을 갖습니다.


자산 수익률


고용 자본 수익률


과거 성과가 우수한 기업 찾기